GetTopicDetailResponse(id=bf6758e90bf, topicName=施一公, introduction=施一公, content=null, image=null, comments=4, allHits=2260, url=https://h5.medsci.cn/topic?id=58790, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1242, tagList=[TagDto(tagId=1242, tagName=施一公)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2108773, encodeId=08d82108e731a, content=<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>團(tuán)隊(duì)發(fā)現(xiàn)<a href='/topic/show?id=41ef26683f' target=_blank style='color:#2F92EE;'>#APOE4#</a>受體，揭示<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿爾茨海默病#</a>最強(qiáng)風(fēng)險(xiǎn)因子致病原因, objectTitle=施一公團(tuán)隊(duì)發(fā)現(xiàn)APOE4受體，揭示阿爾茨海默病最強(qiáng)風(fēng)險(xiǎn)因子致病原因, objectType=article, longId=754403, objectId=2ff4e5440347, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=2ff4e5440347, replyNumber=0, likeNumber=183, createdTime=2023-01-04, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2ff4e5440347, moduleTitle=施一公團(tuán)隊(duì)發(fā)現(xiàn)APOE4受體，揭示阿爾茨海默病最強(qiáng)風(fēng)險(xiǎn)因子致病原因, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2ff4e5440347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2090612, encodeId=3751209061275, content=<a href='/topic/show?id=d05010485690' target=_blank style='color:#2F92EE;'>#全球頂尖科學(xué)家#</a><a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>，<a href='/topic/show?id=c87e8829566' target=_blank style='color:#2F92EE;'>#董晨#</a>，<a href='/topic/show?id=c6e06030207' target=_blank style='color:#2F92EE;'>#曹雪濤#</a>，<a href='/topic/show?id=999b98080a7' target=_blank style='color:#2F92EE;'>#陳竺#</a>，<a href='/topic/show?id=94fd1000403a' target=_blank style='color:#2F92EE;'>#韓濟(jì)生#</a>，<a href='/topic/show?id=4b6c10253599' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4b6c10253599' target=_blank style='color:#2F92EE;'>#高福#</a></a>，<a href='/topic/show?id=49c16439190' target=_blank style='color:#2F92EE;'>#湯釗猷#</a>，<a href='/topic/show?id=179710485e5a' target=_blank style='color:#2F92EE;'>#劉力生#</a>等上榜！
另外，<a href='/topic/show?id=a34610003210' target=_blank style='color:#2F92EE;'>#韓家淮#</a>，<a href='/topic/show?id=c5c7980050a' target=_blank style='color:#2F92EE;'>#陳萬(wàn)青#</a>，<a href='/topic/show?id=4b6c10253599' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4b6c10253599' target=_blank style='color:#2F92EE;'>#高福#</a></a>，<a href='/topic/show?id=3c2f9042eaa' target=_blank style='color:#2F92EE;'>#裴端卿#</a>，<a href='/topic/show?id=2d8b104858bf' target=_blank style='color:#2F92EE;'>#王志國(guó)#</a>等也排名相對(duì)靠前。, objectTitle=全球頂尖科學(xué)家排名（第三版）發(fā)布，施一公，董晨，曹雪濤，陳竺，韓濟(jì)生，高福，湯釗猷，劉力生等上榜！, objectType=article, longId=741076, objectId=7346e4107646, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220915/cb795580c37341a2839b4e635e6b954d.jpg, objectUrl=/article/show_article.do?id=7346e4107646, replyNumber=0, likeNumber=0, createdTime=2022-09-27, rootId=0, userName=小小醫(yī)者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7346e4107646, moduleTitle=全球頂尖科學(xué)家排名（第三版）發(fā)布，施一公，董晨，曹雪濤，陳竺，韓濟(jì)生，高福，湯釗猷，劉力生等上榜！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7346e4107646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=897029, encodeId=93b989e029d6, content=<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>創(chuàng)立的<a href='/topic/show?id=4a76919411b' target=_blank style='color:#2F92EE;'>#諾誠(chéng)健華#</a>, objectTitle=今日，施一公創(chuàng)立的諾誠(chéng)健華遞交港股上市申請(qǐng), objectType=article, longId=181491, objectId=8dff18149194, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201910/20191017214151351.jpg, objectUrl=/article/show_article.do?id=8dff18149194, replyNumber=0, likeNumber=165, createdTime=2020-11-05, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dff18149194, moduleTitle=今日，施一公創(chuàng)立的諾誠(chéng)健華遞交港股上市申請(qǐng), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8dff18149194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=897028, encodeId=fb7f89e02822, content=<a href='/topic/show?id=4a76919411b' target=_blank style='color:#2F92EE;'>#諾誠(chéng)健華#</a>是著名科學(xué)家<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>創(chuàng)立，同期的美國(guó)科學(xué)院院士<a href='/topic/show?id=a16768316c5' target=_blank style='color:#2F92EE;'>#王曉東#</a>創(chuàng)立了<a href='/topic/show?id=ac55e188816' target=_blank style='color:#2F92EE;'>#百濟(jì)神州#</a>，可惜<a href='/topic/show?id=4187101280e9' target=_blank style='color:#2F92EE;'>#饒毅#</a>沒有創(chuàng)立公司?，F(xiàn)在百濟(jì)已經(jīng)是巨頭，諾城健華上升很快，<a href='/topic/show?id=f67910401150' target=_blank style='color:#2F92EE;'>#奧布替尼#</a>很厲害！, objectTitle=諾誠(chéng)健華奧布替尼獲美國(guó)FDA批準(zhǔn)開展治療多發(fā)性硬化癥臨床II期研究, objectType=article, longId=202938, objectId=6e7f20293886, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20201019/143455a04a6645338612b98e5e30a5e1.jpg, objectUrl=/article/show_article.do?id=6e7f20293886, replyNumber=0, likeNumber=226, createdTime=2020-11-05, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e7f20293886, moduleTitle=諾誠(chéng)健華奧布替尼獲美國(guó)FDA批準(zhǔn)開展治療多發(fā)性硬化癥臨床II期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6e7f20293886)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
